511 results on '"Clement Annick"'
Search Results
102. [3H]Thymidine Incorporation Does Not Correlate with Growth State in Cultured Alveolar Type II Cells
103. Deep phenotyping, including quantitative ciliary beating parameters, and extensive genotyping in primary ciliary dyskinesia.
104. One-year outcomes in a multicentre cohort study of incident rare diffuse parenchymal lung disease in children (ChILD).
105. Use of ruxolitinib in COPA syndrome manifesting as life-threatening alveolar haemorrhage.
106. Chronic interstitial lung diseases in children: diagnosis approaches
107. Contribution of mutations in genes of the surfactant system to idiopathic interstitial pneumonia (IIP)
108. Multidisciplinary team dedicated to suspected heritable pulmonary fibrosis
109. COPA syndrome restricted to life-threatening alveolar hemorrhages: clinical, pathological, molecular and biological characterization
110. Functional assessment of newly identified SFTPA1 and SFTPA2 mutations in patients with idiopathic interstitial pneumonia (IIP) and lung cancer
111. An observational study of incident diagnoses of children’s diffuse parenchymal lung disease (ChILDEU)
112. Pleuropulmonary bastoma in children: an unusual presentation mimicking pneumonia
113. Prophylactic azithromycin in patients with primary ciliary dyskinesia.
114. Genetic causes and clinical management of pediatric interstitial lung diseases
115. Growth and nutritional status, and their association with lung function: a study from the international Primary Ciliary Dyskinesia Cohort
116. Eosinophilic Pneumonias in Children: A Review of the Epidemiology, Diagnosis, and Treatment
117. Mutations in GAS8, a Gene Encoding a Nexin-Dynein Regulatory Complex Subunit, Cause Primary Ciliary Dyskinesia with Axonemal Disorganization
118. International management platform for children’s interstitial lung disease (chILD-EU)
119. Analysis of children’s diffuse parenchymal lung disease from the European Management Platform for Childhood Interstitial Lung Diseases: Frequency of disease categories and treatments used
120. Installation of a Multidisciplinary team (MDT) review board for children´s interstitial lung disease (ILD)
121. SFTPA mutations in interstitial lung disease (ILD) and lung cancer
122. The international primary ciliary dyskinesia cohort (iPCD Cohort): methods and first results
123. Surfactant protein A: A key player in lung homeostasis
124. Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis
125. Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.
126. Retinoic acid-induced proliferation of lung alveolar epithelial cells is linked to [p21.sup.CIP1] downregulation
127. Loss-of-Function Mutations in a Human Gene Related to Chlamydomonas reinhardtii Dynein IC78 Result in Primary Ciliary Dyskinesia
128. Management of children with interstitial lung diseases: the difficult issue of acute exacerbations
129. French translation and linguistic validation of the QOL-PCD, a quality of life questionnaire for patients with primary ciliary dyskinesia
130. GermlineSFTPA1mutation in familial idiopathic interstitial pneumonia and lung cancer
131. Phenotype heterogeneity in a familial “brain lung thyroid syndrome” related to a novelNKX-2.1mutation
132. European idiopathic pulmonary fibrosis Patient Charter: a missed opportunity
133. Mutations inGAS8, a Gene Encoding a Nexin-Dynein Regulatory Complex Subunit, Cause Primary Ciliary Dyskinesia with Axonemal Disorganization
134. Respiratory Distress, Congenital Hypothyroidism and Hypotonia in a Newborn
135. RSPH3 Mutations Cause Primary Ciliary Dyskinesia with Central-Complex Defects and a Near Absence of Radial Spokes
136. Effectiveness of palivizumab in children with childhood interstitial lung disease: The French experience
137. <italic>Stenotrophomonas maltophilia</italic>: A marker of lung disease severity.
138. Ancestral haplotype 8.1 and lung disease severity in European cystic fibrosis patients
139. Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis
140. Rare localization of NUT midline carcinoma revealed by pneumonia and pleural effusion in a 13 years old patient: A case report
141. A rare diagnosis after pediatric tuberculosis screening
142. Spontaneous pneumothorax caused by mesenchymal cystic hamartoma in a fifteen year-old girl
143. Genetic testing in idiopathic interstitial pneumonia
144. Inorganic exposome in pediatric sarcoidosis: The PEDIASARC study
145. Gaz exchange, nasal nitric oxyde levels and lung function tests in children with primary ciliary dyskinesia
146. LATE-BREAKING ABSTRACT: Lung function in patients with primary ciliary dyskinesia (PCD): A multinational study
147. RSPH3 Mutations Cause Primary Ciliary Dyskinesia with Central-Complex Defects and a Near Absence of Radial Spokes
148. Cystic fibrosis and AA amyloidosis: a survey in the French cystic fibrosis network
149. Lung disease modifier genes in cystic fibrosis
150. Flagellin concentrations in expectorations from cystic fibrosis patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.